|
Six Key Facts about BioTrinity 2008
BioTrinity 2008 -
Oxford, April 15-16, 2008
With just 5 weeks to go before BioTrinity 2008 can you
afford to be missing from the list of over 260 delegates from over
175 companies already confirmed for April 15-16
in
Oxford?
Register soon to ensure
that your partnering profile appears in the printed conference book
(March 18th 5.00 PM GMT)
The updated programme
for BioTrinity has now been published online and can be
downloaded: http://tinyurl.com/2j7f2a
Take a look at the other
Companies Attending listed below
Six key facts about BioTrinity 2008 -
Oxford
-
Largest biopartnering conference in South-East
England
-
260 delegates from 175 companies already confirmed
(expect 450)
-
Partnering is live:
meeting requests are climbing fast
-
Uniquely your meetings will be held in private
rooms
-
-
Six companies recently confirmed as
attending: Orion Healthcare Equity Partners, Spirogen,
Avecia Biologics, Oxford
BioMedica, ChemoCentryx, Bristol Myers
Squibb.
...........................................................................................
BioTrinity 2007 testimonials:
"...I would like to congratulate you on an excellent
meeting.."
Tim Haines, Partner, Abingworth
Management
"...Congratulations on such a good event. I had a
very productive day with lots of organized and impromptu meetings -
a very worthwhile event for me."
Dr Charles Potter, CEO,
Glide Pharma
Read more
testimonials...
...........................................................................................
a2sp Limited (COO)
AbD Serotec
Ablynx (CEO and
Chairman)
Addos Consulting Director
Amphora Research Systems
(CTO)
AMRI
APA Parafricta (CEO)
Aptuit Inc
Argenta
Discovery (SVP)
AS-Tec Chemicals (Director)
AstraZeneca (VP
Deal Management)
Atlas Venture (Principal)
Avecia Biologics
(CSO)
Beer and Partners
Benezech-Simpson (President) -
France
Berlin Partner GmbH (Germany)
Biocompatibles
BioDynamics Research Ltd
BioMed
Central
BioPark
BioProcess (UK)
BioProcess Technology
Consultants, Inc. (VP)
BioReliance Ltd
Biotech-IgG (UK) Ltd
(CEO)
BioVex (SVP Product Development)
Blake Lapthorn Tarlo
Lyons (Partner)
Bristol-Myers Squibb (Licensing Manager, Europe)
British Consulate in Lyon (France)
BTG
CABI (Director)
Cambridge Healthcare & Biotech (Chairman & CEO)
Canaccord Capital (MD)
Capsant Neurotechnologies (CSO)
Celleron Therapeutics (Director)
Charles River (Director)
Charles Russell Solicitors
Chemocentryx (CEO)
Chroma
Therapeutics
CLIK Knowledge Transfer
CMP Therapeutics (CEO)
Cobra Biomanufacturing Plc (Director)
Cogenics
Cognitive
Drug Research
Communications Strategy Group Inc. (President) -
USA
Constella Group (Director)
Covance
Cresset
BioMolecular Discovery (Director)
D2M (Medicinal Chemistry)
De Facto Communications (CEO)
Defined Health (MD) -
Switzerland
DiagnOx
Dotmatics (CEO)
EBD Group, Inc
Eden
BioDesign (CEO)
EISC Ltd (Director)
Elastictime
limited
Epidyme (Director)
Equinox Pharma
Evotec UK
Limited (EVP)
Finance South East
Focus
Insurance
FP7UK
Frank B. Dehn & Co
Fry Heath
Spence
Genzyme (VP and GM)
George James Ltd
Giles
Insurance Brokers
Glide Pharma (CEO)
Glycoform (CEO)
G-Nostics (CEO)
Goodwin Proctor LLP (Partner) – USA
Grant Thornton
Halo Consulting
Helvoet Pharma (Director)
– Belgium
HFL Ltd
Hybrid Systems (CEO)
Ilika
Technologies Ltd (Director)
Imperial College
Industrial
Design Consultancy Ltd (MD)
Innovator Capital (Director)
International Bioscience (CEO) - USA
InterRea
International
IPI Bradford
iQur (CEO)
Isis
Innovation
Ithaka Life Sciences Ltd
J A Kemp & Co
Karus
Therapeutics (CEO)
La Jolla Pharmaceutical (CFO) - USA
Lab
Support UK Ltd
Lein Applied Diagnostics (Director)
LLC
Associates (Director)
Lovells (Of Counsel)
Maddison Limited
(MD)
Manches (Partner)
Marks & Clerk Patent
Attorneys
MediGene (VP)
MEPC Milton Park (CEO)
Merck
Sharp Dohme (Director)
Millipore
Momentum Bioscience Ltd
(CEO)
Morrison & Foerster MNP (Of Counsel)
MP Healthcare
Venture Management (VP) - USA
M-Scan Ltd
NDA
Analytics
Netherlands Foreign Investment Agency (Director)
Novasep Synthesis
NPIL Pharma
O2H (CEO)
OakBridge
Global Executive Search (Partner)
OBN (Director)
O'Bryan-Tear Consulting Ltd (MD)
Orion Healthcare Equity
Partners
Osborne Clarke (Partner)
OSI Prosidion (CEO)
Oxford BioMaterials (CEO)
Oxford BioPharma (MD)
Oxford
Brookes University
Oxford Capital Partners (Co-founder)
Oxford Expression Technologies (Director)
Oxford Gene
Technology IP Ltd (CEO)
Oxford Genome Sciences (CEO)
Oxford
Innovation
Oxford Outcomes Ltd (Director)
Peakdale Molecular
Ltd
PGXIS (CSO)
Pharmacelsus MedNet (Germany)
PharmaVentures (Director)
Pharmidex (CEO)
Phynova (CEO)
Physiomics plc
PIA Commercial
PiR Group (MD)
PiR
Interims (MD)
Proteros Biostructures GmbH (VP)
Pulse
Scientific
RDP Associates (Director)
Reed
Scientific
Ridepharm (Partner) - Switzerland
RSSL
Pharma
Ruston Poole International
Scottish Biomedical
(Director)
SEEDA
SEHTA (CEO)
Selcia
semgine
GmbH
Shire Pharma (VP Licensing)
Siegfried
Simbec Research
Limited
Smith & Nephew
Sofinnova Partners (Partner)
Solace Pharma (CEO)
Solvias AG - Switzerland
Spirogen
(CEO)
SR One (Partner)
SRG Executive
Stimutran Interreg
Network - Pan-European
Summit plc (CEO)
SynCo BioPartners
(CEO) - Netherlands
Syntaxin (CEO)
Synth-Isis Ltd (MD)
Talentmark Executive Search (VP)
Taylor Wessing
LLP
Tessella Support Services plc (Director)
Thames Valley
Life Sciences Network
The Oxford Science Park
Thermo Fisher
Scientific
Thomson Scientific
Ubichem plc
UK Trade and
Invest
University of Reading
ViroClinics BVM (CEO) -
Belgium
Wellcome Trust
Xiota (Principal)
Register online now: www.biotrinity.com
...........................................................................................
BioTrinity 2008 - Oxford: Prepare to
Partner!
If you are on the partnering circuit this year consider
registering for our BioTuesday event on maximising
value from BioPartnering held in Oxford one month before BioTrinity
2008 on March 18th, to make sure you gain the most value from
biopartnering. Featuring a highly experienced pharma partnering
speaker from Eli Lilly and a partnering system insider from EBD
group.
When spending time at BioTrinty 2008 don't forget
that Oxford is a beautiful and historic city: Visit Oxford.
............................................................................................
Contact details:
Aruna Dudhia – Events Manager OBN
Suite L, Park House
11 Milton Park, Abingdon
Oxfordshire OX14 4RA
Tel. +44 (0)
1865 594640
Fax. +44 (0) 1235 835843
aruna.dudhia@oxfordshirebioscience.net
Register online now at www.biotrinity.com
............................................................................................
BioTrinity sponsors
  
  
  
  
 
............................................................................................
BioTrinity partners
  
  
............................................................................................
BioTrinity is organised by OBN
|
)